HuagongsheHuagongshe Chemistry Print Report · For research reference only
Lithium borohydride → Methyl 13-cyclohexyl-6-(hydroxymethyl)-5-methyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepine-10-carboxylate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Lithium borohydride | HCID 4148881 | — |
| Reactant | Dimethyl 13-cyclohexyl-5-methyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepine-6,10-dicarboxylate | HCID 66674609 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | Methyl 13-cyclohexyl-6-(hydroxymethyl)-5-methyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepine-10-carboxylate | HCID 66674023 | 80% |
Reaction Steps
Dimethyl 13-cyclohexyl-5-methyl-6,7-dihydro-5H-indolo[1,2-d][1,4]benzodiazepine-6,10-dicarboxylate was dissolved in anhydrous THF (0.05M) and LiBH4 (1 eq) was added. The mixture was stirred at RT. After 1 h only marginal conversion to the product was observed. BH3-THF complex (1 eq) was added and the mixture was stirred at RT. After 2 h a further equivalent of BH3-THF complex was added and the mixture was stirred for 2 h. The mixture was quenched by addition of silica gel and all volatiles were evaporated in vacuo. The product was isolated by FC (PE:EtOAc, 8:2). After evaporation of the solvents the product was obtained as a colourless solid (80%). (ES+) m/z 419 (M+H)+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07989438B2 |
| Source dataset | uspto-grants-2011_08 |
| ORD ID | ord-8bf076fb18c64e60a73409cba4013c6a |
| Source note | uspto-grants-2011_08 |